deltatrials

Rheumatoid arthritis Trials in Smithtown, United States

Conditions / Rheumatoid arthritis / Smithtown, United States

Clinical trials for Rheumatoid arthritis investigate a range of treatment strategies and patient populations.

25 total trials for this combination

Showing top 10 of 25 trials

Trials

NCT ID Title Status Phase
NCT00783991 Investigating the Impact of Mode of Administration on Item Response COMPLETED
NCT00443443 A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE) COMPLETED
NCT01146652 Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND) COMPLETED PHASE3
NCT00468546 A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy COMPLETED PHASE3
NCT00717236 Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis COMPLETED PHASE3
NCT01242514 Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA) TERMINATED PHASE3
NCT00124982 Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy COMPLETED PHASE3
NCT00891020 A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs) COMPLETED PHASE3
NCT00106574 A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis COMPLETED PHASE3
NCT00476996 A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT) TERMINATED PHASE3

Related Pages